Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 4;14(6):e242853.
doi: 10.1136/bcr-2021-242853.

Acute icteric hepatitis as the first isolated symptom of COVID-19

Pierre-Clément Thiebaud  1 , Christelle Hermand  2 , Jennifer Sobotka  2 , Pierre-Alexis Raynal  2
Affiliations
Case Reports

Acute icteric hepatitis as the first isolated symptom of COVID-19

Pierre-Clément Thiebaud et al. BMJ Case Rep. .

Abstract

Patients with COVID-19 may be asymptomatic or present with extrarespiratory symptoms, such as liver injury. It has been reported that 22.5%-46.2% of patients have moderate elevation of liver enzymes. To our knowledge, acute hepatitis has never been described as an isolated symptom of COVID-19 in a previously healthy patient. We report the case of a 53-year-old patient with COVID-19 whose first clinical presentation was acute icteric hepatitis, several days before the development of others symptoms. During the pandemic, we suggest that patients with acute hepatitis be considered as COVID-19 suspects, tested and isolated.

Keywords: COVID-19; hepatitis and other GI infections; hepatitis other.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

Cited by

References

    1. Ding ZY, GX L, Chen L. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol 2020;S0168-8278(20)33885-X. - PubMed
    1. Hao S-R, Zhang S-Y, Lian J-S, et al. . Liver enzyme elevation in coronavirus disease 2019: a multicenter, retrospective, cross-sectional study. Am J Gastroenterol 2020;115:1075–83. 10.14309/ajg.0000000000000717 - DOI - PMC - PubMed
    1. Phipps MM, Barraza LH, LaSota ED, et al. . Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. cohort. Hepatology 2020;72:807–17. 10.1002/hep.31404 - DOI - PMC - PubMed
    1. Yip TC-F, Lui GC-Y, Wong VW-S, et al. . Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Gut 2021;70:gutjnl-2020-321726. 10.1136/gutjnl-2020-321726 - DOI - PubMed
    1. Villerabel C, Makinson A, Jaussent A, et al. . Diagnostic value of patient-reported and clinically tested olfactory dysfunction in a population screened for COVID-19. JAMA Otolaryngol Head Neck Surg 2021;147:271–9. 10.1001/jamaoto.2020.5074 - DOI - PMC - PubMed

Publication types